Try our beta test site
2 studies found for:    alzheimer, comentis
Show Display Options
Rank Status Study
1 Completed GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease
Condition: Alzheimer Disease
Intervention: Drug: DMXB-A
2 Completed Safety Study of CTS21166 to Treat Alzheimer Disease
Condition: Alzheimer's Disease
Intervention: Drug: CTS21166 (ZPQ-21166)

Study has passed its completion date and status has not been verified in more than two years.